Immunohistochemical Detection of CD44 Splice Variant Expression in Premalignant Lesions of the Cervix and Benign Cervical Epithelium
- 31 August 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 66 (2) , 227-232
- https://doi.org/10.1006/gyno.1997.4748
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prognostic value of CD44 splice variants in human stage III cervical cancerEuropean Journal Of Cancer, 1995
- Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIBGynecologic Oncology, 1995
- Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of chinese subjectsCancer, 1995
- De-novo expression of CD44 and survival in gastric cancerThe Lancet, 1993
- Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular originThe Journal of cell biology, 1993
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Rapid Communication—The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses—Report of the 1991 Bethesda WorkshopJAMA, 1992
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991